Home
  >  
Section 11
  >  
Chapter 10,087

A pivotal role of activated hepatic macrophage in the progression of alcoholic liver disease

Yamada, S.

Journal of Uoeh 21(1): 37-45

1999

ISSN/ISBN: 0387-821X
PMID: 10202791
DOI: 10.7888/juoeh.21.37
Accession: 010086728
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Our clinical and experimental research results indicated the possibility that gut-derived endotoxin contributes to the development of alcoholic liver disease. Long-term ethanol consumption resulted in an enhanced secretory function of hepatic macrophage accompanied by an ultrastructural feature of activation. The liver of rats fed on ethanol-diet were found to have an enhanced ability to produce CINC-1 (rat IL-8) after endotoxin injection. This chemokine may contribute to neutrophil recruitment into the liver in alcoholic liver injury. Females exhibited a greater ability to produce CINC-1 than males, and this fact may account for the gender difference in susceptibility to alcohol-related liver disease.

PDF emailed within 0-6 h: $19.90




Related References

Wang, M.; Frasch, S.Courtney.; Li, G.; Feng, D.; Gao, B.; Xu, L.; Ir, D.; Frank, D.N.; Bratton, D.L.; Ju, C. 2017: Role of gp91 phox in hepatic macrophage programming and alcoholic liver disease Hepatology Communications 1(8): 765-779
Bukong, T.N.; Lo, T.C.; Sato, K.; Tournade, C.D.; Dolganiuc, A. 2013: Su1716 Large-Conductance Calcium-Activated Potassium (MaxiK) Channels Protect From Progression of Hepatic Steatosis (Hs) to Steatohepatitis (Hs) in Alcoholic Liver Disease (Ald) in Mice Gastroenterology 144(5): S-1005
Masuda, K.; Noguchi, S.; Ono, M.; Ochi, T.; Munekage, K.; Okamoto, N.; Suganuma, N.; Saibara, T. 2017: High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus Hepatology Research: the Official Journal of the Japan Society of Hepatology 47(10): 983-990
Kakino, S.; Ohki, T.; Nakayama, H.; Yuan, X.; Otabe, S.; Hashinaga, T.; Wada, N.; Kurita, Y.; Tanaka, K.; Hara, K.; Soejima, E.; Tajiri, Y.; Yamada, K. 2018: Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model Hormone and Metabolic Research 50(1): 80-87
Ekstedt, M.; Franzén, L.E.; Holmqvist, M.; Bendtsen, P.; Mathiesen, U.L.; Bodemar, Göran.; Kechagias, S. 2009: Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease Scandinavian Journal of Gastroenterology 44(3): 366-374
Hirano, T.; Kamimura, S.; Fernandez Checa, J.; Kaplowitz, N.; Tsukamoto, H. 1992: Selective depletion of hepatic mitochondrial GSH in progression of experimental alcoholic liver disease Hepatology 16(4 Part 2): 90A
Zhong, L.; Xu, K.S.; Deng, L. 2020: Study on the state of macrophage infiltration in the progression of non-alcoholic fatty liver disease induced by high-fat diet in mice Zhonghua Gan Zang Bing Za Zhi 28(12): 1042-1047
Hirano, T.; Kaplowitz, N.; Tsukamoto, H.; Kamimura, S.; Fernandez-Checa, J.C. 1992: Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats Hepatology 16(6): 1423-1427
Hirano, T.; Kaplowitz, N.; Tsukamoto, H.; Kamimura, S.; Fernandezcheca, J.C. 1992: Hepatic mitochondrial glutatathione depletion and progression of experimental alcoholic liver disease in rats Hepatology (Baltimore, Md.) 16(6): 1423-1427
Machado, M.V.; Michelotti, G.A.; Pereira, T.A.; Xie, G.; Premont, R.; Cortez-Pinto, H.; Diehl, A.M. 2015: Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease Journal of Hepatology 63(4): 962-970
Liu, Y-Lin.; Reeves, H.L.; Burt, A.D.; Tiniakos, D.; McPherson, S.; Leathart, J.B.S.; Allison, M.E.D.; Alexander, G.J.; Piguet, A-Christine.; Anty, R.; Donaldson, P.; Aithal, G.P.; Francque, S.; Van Gaal, L.; Clement, K.; Ratziu, V.; Dufour, J-Francois.; Day, C.P.; Daly, A.K.; Anstee, Q.M. 2014: TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nature Communications 5: 4309
Peters, K.M.; Wilson, R.B.; Borradaile, N.M. 2018: Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis Current Opinion in Lipidology 29(5): 417-422
Upchurch, C M; Serbulea, V; Leitinger, N 2017: Dynamic Oxidized Phospholipid Composition within the Liver Plays a Role in Non-alcoholic Fatty Liver Disease Progression Free Radical Biology and Medicine 112: 177-178
Castro, P.Cenira.Senger.de.; Alberton, H.Caroline.Perussolo.; Pedroso, M.Lucia.Alves.; Morsoletto, D.Benatti.Gonçalves.; Pissaia Junior, A.; Ivantes, Cáudia.Alexandra.Pontes. 2019: Evaluation of Progression of Hepatic Fibrosis in a Group of Patients with Non-Alcoholic Fatty Liver Disease Accompanied for 10 Years Arquivos de Gastroenterologia 56(3): 256-260
Ryaboshapkina, M.; Hammar, Mårten. 2017: Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis Scientific Reports 7(1): 12361
Heo, J.H.; Lee, S.R.; Jo, S.L.; Ko, J.-W.; Kwon, H.-J.; Hong, E.-J. 2021: Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling International Journal of Molecular Sciences 22(15)
Zeybel, M.üj.; Hardy, T.; Robinson, S.M.; Fox, C.; Anstee, Q.M.; Ness, T.; Masson, S.; Mathers, J.C.; French, J.; White, S.; Mann, J. 2015: Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease Clinical Epigenetics 7: 25
Zhang, X.; Thompkins-Johns, A.; Ziober, A.; Zhang, P.J.; Furth, E.E. 2022: Hepatic Macrophage Types Cluster with Disease Etiology in Chronic Liver Disease and Differ Compared to Normal Liver: Implications for their Biologic and Diagnostic Role International Journal of Surgical Pathology 2022: 10668969221099630
Amir, M.; Yu, M.; He, P.; Srinivasan, S. 2020: Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease Frontiers in Medicine 7: 62
Yuan, X.; Chen, J.; Cheng, Q.; Zhao, Y.; Zhang, P.; Shao, X.; Bi, Y.; Shi, X.; Ding, Y.; Sun, X.; Xue, B. 2018: Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery Bmc Gastroenterology 18(1): 147